Quantres Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-75,900
Closed -$4.75M 175
2018
Q4
$4.75M Buy
+75,900
New +$5.31M 2.93% 3
2018
Q2
Sell
-17,200
Closed -$1.3M 219
2018
Q1
$1.3M Sell
17,200
-35,600
-67% -$2.83M 0.79% 33
2017
Q4
$3.78M Buy
52,800
+39,300
+291% +$2.98M 2.38% 2
2017
Q3
$1.09M Buy
+13,500
New +$1.03M 0.7% 43
2017
Q1
Sell
-4,600
Closed -$329K 189
2016
Q4
$329K Sell
4,600
-24,400
-84% -$1.81M 0.23% 119
2016
Q3
$2.29M Buy
+29,000
New +$2.36M 1.42% 13
2016
Q2
Sell
-11,300
Closed -$1.04M 194
2016
Q1
$1.04M Buy
+11,300
New +$1.02M 1% 33
2015
Q4
Sell
-5,600
Closed -$550K 141
2015
Q3
$550K Sell
5,600
-1,000
-15% -$111K 0.43% 63
2015
Q2
$773K Buy
6,600
+1,200
+22% +$131K 0.61% 53
2015
Q1
$530K Sell
5,400
-100
-2% -$10.2K 0.53% 59
2014
Q4
$518K Buy
+5,500
New +$569K 0.5% 65
2014
Q2
Sell
-25,500
Closed -$1.81M 185
2014
Q1
$1.81M Buy
+25,500
New +$2M 2.12% 1

Other funds holding GILD

Quantres Asset Management's GILD Position: Q1 2019 in Review

Quantres Asset Management sold out of Gilead Sciences (GILD) in Q1 2019, closing a stake of 75,900 shares — an estimated $4.75M sold.

Quantres Asset Management first reported a position in GILD in Q1 2014 and held it in 12 quarters. The position peaked at $4.75M in Q4 2018. 1,492 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

  • Quantres Asset Management reported no remaining Gilead Sciences position as of Q1 2019 after selling out during the quarter.
  • Quantres Asset Management sold 75,900 Gilead Sciences shares in Q1 2019, an estimated $4.75M.
  • Quantres Asset Management first reported a position in Gilead Sciences in Q1 2014 and held it in 12 quarters.
  • Quantres Asset Management's Gilead Sciences position peaked at $4.75M in Q4 2018.
  • 1,492 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on Quantres Asset Management's 13F filing for Q1 2019, filed 12 Apr 2019.